From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

easyJet – a buy for further share price recovery?

By HotStockRockets | Friday 4 November 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


This company is somewhat bigger than the ones we usually cover, but it struck us as a relatively low risk trading buy and, although already well up from a below 300p tip price at approaching 350p, there looks some more to go. This follows a recent trading update from easyJet (EZJ) having emphasised continuing demand for its leading network alongside “step-changed” ancillary revenue and the rapid and profitable growth of the easyJet holidays business. The shares responded positively, but were above 400p as recently as August and above 700p earlier this year and, despite some clear challenges, we suggest that there is further recovery potential from here as we look to 29th November-scheduled results and beyond.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 06:17:35